Page 4 - Interferon Beta News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Visiongain has published a new report on Multiple Sclerosis Drugs Market Report 2021-2031:Forecasts By Drug Class (Corticosteroids, Interferon Beta,...

Vancouver, British Columbia--(Newsfile Corp. - December 2, 2021) - Biocure Technology Corp. (CSE: CURE) (OTCQB: BICTF) ("Biocure" or the "Company") is pleased to provide the following operational and

Biocure Technology Inc.: BioCure Technology Inc. Announces Closing of Financing Vancouver, British Columbia--(Newsfile Corp. - July 14, 2021) - BioCure Technology Inc. (CSE: CURE) ("BioCure" or the "Company") announces that it has successfully closed a non-brokered private placement (the "Private Placement") consisting of 6,706,525 Units at a price of $0.16 cents per Unit for gross proceeds of $1,073,044.00 Each Unit is comprised of one common share (the "Shares") and one share purchase warrant (the "Warrants") of the Company, where each whole Warrant entitles the holder to purchase an additi...

Vaccines have received all the attention but they are not humanity’s only weapon against coronavirus: we also have treatments. One is made by Synairgen, whose Covid-19 remedy consists of a naturally occurring antiviral protein, interferon beta, that is delivered directly to where it counts: the patient’s lungs. While we all hope the vaccines will provide our path out of the pandemic there remains the fear that vaccine-resistant variants will allow the virus to stay one step ahead. If this happen

UK, with high hopes of helping Covid-19 patients stop developing serious illness. The new treatment involves inhaling a protein called Interferon Beta, which the body produces in infection. The hope is that this will stimulate the immune system and the cells will be prepared to fight viruses. Initial results from the trials showed that treatment reduced by nearly 80 percent the chances of patients in hospital with Covid-19 developing severe diseases. Results from phase two trials of around 100 patients last year also indicated “very significant” reductions in breathlessness, while the ave...